Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Research by G. Copeland and colleagues in cancer vaccines provides new insights
December 16th, 2008
Fresh data on cancer are presented in the report 'Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003.' "With the recent licensure of a vaccine that protects against human papillomavirus (HPV) types 16 and 18, US women are expected to experience lower rates of cervical cancer. However, surveillance systems must be in place in the US to measure the real-world effectiveness of vaccination programs," researchers in the United States report. "Although population-based registries will provide invasive cervical cancer (ICC) incidence and burden data, the impact of HPV vaccine on cervical cancer will not be measurable for several...
Source: Cancer Weekly (2008-12-16)
|
